编者按：第 11 届亚太人类遗传学大会（APCHG 2015）于 9 月 16-18 日在越南河内顺利召开。本届大会以“Genetics and Genomics: The Path to Translational Medicine”为主题，旨在为参会人员提供一个讨论人类遗传学进展的平台。本次大会上，400 份 AME 旗下 Annals of Translational Medicine（简称 ATM）杂志会议专辑，800 份 Translational Pediatrics（简称 TP）杂志两期特刊宣传页被放入会议资料包，送达到 400 余位参会人员的手中。小编也很荣幸邀请到来自日本 National Center of Neurology and Psychiatry 的 Prof. Ichizo Nishino 教授接受我们的专访。Prof. Nishino 在报告中分享了肌肉疾病近年的进展，也用详细的数据展示了肌肉疾病面临的现状，比如发展中国家肌肉疾病专家的严重缺乏，引人深思。
First could you please briefly introduce yourself to our audience, including your research interests?
Today you gave an excellent speech on “Next generation sequencing analysis on heredity muscle disease”, could you give a summary on your main points of your report? What shall we expect/learn from the report?
We notice you have been working on muscle disease for a long time, how do you see the advances in treatment of muscle disease over the past years?
In your report, you point out some critical status of treatment of the disease, for example, the severe shortage of relevant experts in developing countries. Could you specify it?
Impressive! Since there is great gap between developed countries and developing countries in dealing with muscle disease. How should experts be better trained from you perspective? What’s your suggestion?
受访专家|Ichizo Nishino, M.D., PhD. Prof. Ichizo Nishino is the Director of Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Japan. He is also Director of Department of Medical Genome Development, Medical Genome Center, NCNP. Prof. Nishino is a Guest Professor at Waseda University and University of Yamanashi, and a Visiting Professor at National Chiao Tung University, Taiwan. Prof. Nishino obtained his M.D. in 1989 from Kyoto University, Faculty of Medicine, Japan. After five years of training in clinical neurology, he started muscle disease research. Since then, he has published more than 370 PubMed-listed papers in the field, including the identification of causative genes for Danondisease and MNGIE.